Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kreuzberg

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Der Internist|February 2, 2013
[Personalized therapy concepts for malignant melanoma]M Schlaak, N Kreuzberg, C Mauch, et al.
ESMO Open|December 7, 2025
Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case reportD Smarsly, N Kreuzberg, C Langhorst, et al.
The British Journal of Dermatology|March 27, 2013
Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patientsM Schlaak, A Bajah, T Podewski, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Der Internist|February 2, 2013
[Personalized therapy concepts for malignant melanoma]M Schlaak, N Kreuzberg, C Mauch, et al.
ESMO Open|December 7, 2025
Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case reportD Smarsly, N Kreuzberg, C Langhorst, et al.
The British Journal of Dermatology|March 27, 2013
Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patientsM Schlaak, A Bajah, T Podewski, et al.
Pageof 1